REG - EKF Diagnostics Hldg - Result of AGM

EKF Diagnostics HoldingsAnnouncement

Today 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260519:nRSS9450Ea&default-theme=true

RNS Number : 9450E  EKF Diagnostics Holdings PLC  19 May 2026

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics
business, announces that at its Annual General Meeting ("AGM") held earlier
today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

             For                  Against             Withheld
 Resolution  Votes        %       Votes       %       Votes
 1           312,253,138  99.99%  1,264       0.01%   1,898,738
 2           313,692,073  99.98%  57,692      0.02%   403,375
 3           310,167,438  99.83%  522,512     0.17%   3,463,190
 4           260,764,981  98.51%  3,945,880   1.49%   49,442,279
 5           313,692,073  99.98%  57,692      0.02%   403,375
 6           313,692,073  99.98%  57,692      0.02%   403,375
 7           309,356,290  98.60%  4,394,675   1.40%   402,175
 8           313,740,420  99.99%  10,545      0.01%   402,175
 9           312,195,470  99.51%  1,524,460   0.49%   433,210
 10*         310,059,158  98.83%  3,658,772   1.17%   435,210
 11*         258,929,660  82.54%  54,788,270  17.46%  435,210
 12*         253,090,453  82.77%  52,698,677  17.23%  8,364,010
 13          174,808,673  95.16%  8,887,971   4.84%   3,406,496

 

*denotes a Special Resolution

 

 EKF Diagnostics Holdings plc                                                 www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Julian Baines, Executive Chair / Gavin Jones, Chief Executive Officer         via Walbrook PR

 Singer Capital Markets (Nominated Adviser & Broker)                          Tel: +44 (0)20 7496 3000
 Phil Davies / Patrick Weaver

 Walbrook PR Limited                  Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Alice Woodings        Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

 

EKF is an AIM-listed global diagnostics business focussed on:

 

 ●    Point-of-Care analysers in the key areas of Hematology and Diabetes
 ●    Life Sciences services provide specialist manufacture of enzymes and custom
      products for use in diagnostic, food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing
sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSFDFFUEMSEEI



            Copyright 2019 Regulatory News Service, all rights reserved